DANIELLE CALVILLO: Open Payments
NPI 1295431500 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,065 in 98 payments from 24 companies in 2025. Trend: 2023 $117 · 2024 $1,038 · 2025 $2,065
Food & beverage: $1,866Education: $199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $497 |
| Astellas Pharma US Inc | 8 | $408 |
| AstraZeneca Pharmaceuticals LP | 6 | $246 |
| PFIZER INC. | 8 | $141 |
| Novo Nordisk Inc | 7 | $128 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $61 |
| Lilly USA, LLC | 4 | $58 |
| Tonix Medicines, Inc. | 2 | $53 |
| Axsome Therapeutics, Inc. | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
Products named: VRAYLAR, Veozah, FARXIGA, QULIPTA, NURTEC ODT, Wegovy, AIRSUPRA, UBRELVY.
Industry payments across NE — which companies pay providers there.
